University of Chicago Comprehensive Cancer Center

Leukemia Research Foundation Awards $2.4M in Research Grants

Retrieved on: 
Freitag, September 29, 2023
University, Peter Doherty (immunologist), Research, Associate, Bangladesh Technical Education Board, Creativity, MD, Hospital, Leukemia, St. Jude Children's Research Hospital, NIH, University of Chicago Comprehensive Cancer Center, MAB, Pharmaceutical industry, Nursing

NORTHFIELD, Ill., Sept. 29, 2023 /PRNewswire-PRWeb/ -- The Leukemia Research Foundation is pleased to award $2.4M in research grants through its 2023 New Investigator Research Grant Program.

Key Points: 
  • The Leukemia Research Foundation is pleased to award $2.4M in research grants through its 2023 New Investigator Research Grant Program.
  • NORTHFIELD, Ill., Sept. 29, 2023 /PRNewswire-PRWeb/ -- The Leukemia Research Foundation is pleased to award $2.4M in research grants through its 2023 New Investigator Research Grant Program.
  • The projects are highly innovative, with the potential to impact broad, essential areas of leukemia research.
  • Grantees named The 16 New Investigator Research Grant recipients for 2023 include:
    St Jude Children's Research Hospital, Inc.
    Peter Doherty Institute at the University of Melbourne, Australia
    To learn more about the Leukemia Research Foundations' research programs, and the deadlines for the 2024 grant program, visit leukemiarf.org/research

FREENOME ADDS UNIVERSITY OF CHICAGO AS A PARTNER FOR ITS VALLANIA STUDY

Retrieved on: 
Mittwoch, April 12, 2023
IPPH, Pancreatic cancer, Partnership, University, CRC, Public, Health promotion, Cancer, Research, Trial of the century, Patient, Risk, Machine learning, Colorectal cancer, University of Chicago Comprehensive Cancer Center, Neoplasm, Health, Nursing, Pharmaceutical industry

SOUTH SAN FRANCISCO, Calif., April 12, 2023 /PRNewswire/ -- Freenome, a privately held biotech company, announced today that the Institute for Population and Precision Health (IPPH) at the University of Chicago has joined as a study partner for its Vallania Study. The Vallania Study began enrollment in 2022 and focuses on the detection of multiple cancers.

Key Points: 
  • The Vallania Study began enrollment in 2022 and focuses on the detection of multiple cancers.
  • The Vallania Study is a key milestone in Freenome's plan to expand early detection of cancer screening beyond colorectal cancer (CRC).
  • The Vallania Study honors the mother of a Freenome scientist who battled pancreatic cancer.
  • Additional information on the Vallania Study can be found on the study webpage or at clinicaltrials.gov .

Prostate Cancer Treatment can be safely delayed, and inexpensively and accurately monitored thanks to new Artificial Intelligence

Retrieved on: 
Dienstag, März 28, 2023
Prostate, Prostate cancer, Urine, Medicine, Dres, The New England Journal of Medicine, Abnormality, CAD, Cancer, Research, University of East Anglia, Standard, NEJM, Metcalfe, Radiation therapy, MRI, University of Chicago Comprehensive Cancer Center, Rectum, Prostate cancer screening, Risk, Artificiality, Blood, Artificial intelligence, PSE, PCA, Diagnosis, Digital, AI, FDA, Standard of care, PSA, Men's Health, Medical imaging, Mobile phone

Therefore, biopsies are not an effective screening tool for prostate cancer, but are a confimatory tool if utilized with imaging guidance.

Key Points: 
  • Therefore, biopsies are not an effective screening tool for prostate cancer, but are a confimatory tool if utilized with imaging guidance.
  • In conclusion, bpMRI with CAD (AI) such as ProstatID, is poised to change the Standard of Care for Prostate Cancer screening, detection and diagnosis by avoiding the costly pitfalls of current prostate cancer pathways.
  • al., Fifteen-year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer, NEJM, March 11, 2023.
  • Circulating Chromosome Conformation Signatures Significantly Enhance PSA Positive Predicting Value and Overall Accuracy for Prostate Cancer Detection.

Medical College of Wisconsin Cancer Center Announces New Training Program to Boost Diversity in Cancer Research

Retrieved on: 
Montag, Februar 27, 2023
University of Wisconsin–Milwaukee, Doctor of Philosophy, Cell biology, Cancer, Prostate cancer, MD, MCW, University of Chicago Comprehensive Cancer Center, ACS, Anatomy, Alverno College, Research, Ace Institute of Health Sciences, Partnership, Neuroscience, Mount Mary University, Mentorship, Diversity, American Cancer Society, American Cancer Society Cancer Action Network, Korea Disease Control and Prevention Agency, Medical College of Wisconsin, Science, Student, Incidence, Medical college, Nursing

MILWAUKEE, Feb. 27, 2023 /PRNewswire/ -- The Medical College of Wisconsin (MCW) Cancer Center today announced a new 2-year training program to improve diversity, equity, and inclusion in cancer research. In partnership with Alverno College, Mount Mary University, UW-Milwaukee, and other Wisconsin universities, the program aims to develop a diverse cancer research workforce – one with the potential to impact cancer disparities in eastern Wisconsin.

Key Points: 
  • Effort Aims to Diversify Research Workforce, Address Regional Cancer Disparities
    MILWAUKEE, Feb. 27, 2023 /PRNewswire/ -- The Medical College of Wisconsin (MCW) Cancer Center today announced a new 2-year training program to improve diversity, equity, and inclusion in cancer research.
  • In partnership with Alverno College, Mount Mary University, UW-Milwaukee, and other Wisconsin universities, the program aims to develop a diverse cancer research workforce – one with the potential to impact cancer disparities in eastern Wisconsin.
  • Funded by the American Cancer Society's (ACS) Center for Diversity in Cancer Research Training , the MCW Cancer Center was one of eight institutions selected to offer the post-baccalaureate program which provides underrepresented students in science with an immersive experience that includes hands-on training in cancer research labs, access to research mentors, participation in community outreach efforts, and career development workshops.
  • Student research via MCW's program will focus on the molecular mechanisms of cancer and cancer health disparities, building on nearly 10 years of cancer disparities research at the MCW Cancer Center.

Moffitt Cancer Center Working to Overcome Health Disparities

Retrieved on: 
Mittwoch, Mai 18, 2022
Cancer, Lymphoma, Breast, Multiple myeloma, H. Lee Moffitt Cancer Center & Research Institute, Education, 2009 Davis Cup, Incidence, Prostate, African Americans, National Cancer Institute, American Nurses Credentialing Center, Lymphatic system, U.S. News & World Report, Time, YouTube, Instagram, Leukemia, University of Chicago Comprehensive Cancer Center, Lung, American Nurses Association, Moffitt, News, Health equity, Nursing, GLOBE, Coffee, Birth control, Black

At Moffitt Cancer Center we are dedicated to prioritizing the needs of the community we serve, and emphasizing the importance of screening, early detection, and prevention.

Key Points: 
  • At Moffitt Cancer Center we are dedicated to prioritizing the needs of the community we serve, and emphasizing the importance of screening, early detection, and prevention.
  • There is a time to understand and address health disparities to achieve health equity; that time is now.
  • To learn more about how you can get involved or to request community outreach services from Moffitt Cancer Center, visit Moffitt.org/COEE .
  • Moffitt Cancer Center is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer.

Moffitt Cancer Center is Engaging the Community Against Cancer

Retrieved on: 
Freitag, April 22, 2022
Navy Office of Community Outreach, Outreach, Health equity, National Cancer Institute, University of Chicago Comprehensive Cancer Center, American Nurses Credentialing Center, Research, MD, H. Lee Moffitt Cancer Center & Research Institute, U.S. News & World Report, YouTube, News, Education, GLOBE, Patient, Moffitt, Man, Prostate cancer, Instagram, Nursing, African Americans, Cancer, MPH, Medicine, Pharmaceutical industry, Equity, Engagement, Doctor of Philosophy, Central Florida, Black

Nationally renowned as a model example, bringing together providers, researchers and the community partners is the mission of Office of Community Outreach, Engagement, and Equity .

Key Points: 
  • Nationally renowned as a model example, bringing together providers, researchers and the community partners is the mission of Office of Community Outreach, Engagement, and Equity .
  • Moffitt Cancer Center encourages minority communities, specifically the Black and African American community, to participate in clinical trials for cancer treatments.
  • To learn more about how you can get involved or to request community outreach services from Moffitt Cancer Center, visit Moffitt.org/COEE .
  • Moffitt Cancer Center is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer.

IMI Releases Tamper Evident Caps with DoseID Certified RFID

Retrieved on: 
Freitag, Februar 25, 2022
Program, IMI, Efficiency, ARC, University of Chicago Comprehensive Cancer Center, List of pharmacy schools, Acosta Sales & Marketing, Doctor of Pharmacy, Auburn University, College, Technology, University, Science and technology in Asia, Radio-frequency identification, Department, Hospital, Security printing, Medical device, Pharmacy, RFID

The DoseID certified RFID Technology presents an opportunity to augment the proven benefits of tamper-evident products.

Key Points: 
  • The DoseID certified RFID Technology presents an opportunity to augment the proven benefits of tamper-evident products.
  • In addition, Tamper Evident Caps with incorporated RFID technology offer a significant reduction in RFID implementation costs.
  • IMI joined DoseID, a consortium of RFID proponents in 2020 to support the interoperability, quality, and performance of RFID tagged products.
  • The DoseID RFID tag, now incorporated in the Prep-Lock Tamper Evident Cap, is certified by Auburn University RFID Lab's ARC Program to ensure the high standards set by the DoseID consortium are met and that those standards meet the needs of the healthcare industry.

City of Hope Named 11th Best Cancer Hospital in the Nation by U.S. News & World Report

Retrieved on: 
Dienstag, Juli 30, 2019
Surgery, Other Health, Other Philanthropy, Other Science, Radiology, Research, Oncology, Hospitals, Genetics, Clinical trials, Foundation, Stem cells, Science, Biotechnology, Practice Management, Managed care, Health, General Health, Philanthropy, Health, National Comprehensive Cancer Network, NCI-designated Cancer Center, University of Florida, UCSF Helen Diller Family Comprehensive Cancer Center, University of Chicago Comprehensive Cancer Center

City of Hope has been named the 11th best cancer hospital in the nation by U.S. News & World Reports 2019-20 Best Hospitals: Specialty Ranking.

Key Points: 
  • City of Hope has been named the 11th best cancer hospital in the nation by U.S. News & World Reports 2019-20 Best Hospitals: Specialty Ranking.
  • This year, U.S. News & World Report added data from Hospital Consumer Assessment of Healthcare Providers and Systems, which tracks exemplary patient experience.
  • City of Hope is one of 50 comprehensive cancer centers in the nation, the highest designation possible from the National Cancer Institute and a metric used by U.S. News & World Report.
  • A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked one of America's "Best Hospitals" in cancer by U.S. News & World Report.